文献
J-GLOBAL ID:201702265729067632
整理番号:17A1456030
アントラサイクリンベースの化学療法の失敗後の進行性子宮平滑筋肉腫患者におけるトラベクテジンまたはダカルバジンの有効性と安全性:第3相,無作為化臨床試験のサブグループ解析【Powered by NICT】
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
著者 (15件):
Hensley Martee L.
(Memorial Sloan Kettering Cancer Center, New York, NY, USA)
,
Patel Shreyaskumar R.
(The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA)
,
von Mehren Margaret
(Fox Chase Cancer Center, Philadelphia, PA, USA)
,
Ganjoo Kristen
(Stanford Hospital and Clinics, Stanford, CA, USA)
,
Jones Robin L.
(Seattle Cancer Care Alliance/University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA)
,
Staddon Arthur
(Arthur James Cancer Center, Columbus, OH, USA)
,
Rushing Daniel
(Indiana University, Simon Cancer Center, Indianapolis, IN, USA)
,
Milhem Mohammed
(University of Iowa Hospitals and Clinics, Iowa City, IA, USA)
,
Monk Bradley
(St. Joseph’s Hospital & Medical Center, Phoenix, AZ, USA)
,
Wang George
(Janssen Research & Development LLC, Raritan, NJ, USA)
,
McCarthy Sharon
(Janssen Research & Development LLC, Raritan, NJ, USA)
,
Knoblauch Roland E.
(Janssen Research & Development LLC, Raritan, NJ, USA)
,
Parekh Trilok V.
(Janssen Research & Development LLC, Raritan, NJ, USA)
,
Maki Robert G.
(Mount Sinai School of Medicine, New York, NY, USA)
,
Demetri George D.
(Dana-Farber Cancer Institute, Harvard Medical School, and Ludwig Center at Harvard, Boston, MA, USA)
資料名:
Gynecologic Oncology
(Gynecologic Oncology)
巻:
146
号:
3
ページ:
531-537
発行年:
2017年
JST資料番号:
E0561C
ISSN:
0090-8258
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)